Nomogram for predicting cumulative risk of CVEs at 48 months with the FG model. As a cohort’s representative, we illustrated a patient with the cohort median values for continuous variables, without diabetes and being treated with lipid-lowering and antihypertensive drugs. With these characteristics, the probability of suffering a CVE after 4 years is estimated to be 4.1%.